Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219,318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
Ai H, Chao NJ, Rizzieri DA, Huang X, Spitzer TR, Wang J, Guo M, Keating A, Krakow EF, Blaise D, Ma J, Wu D, Reagan J, Gergis U, Duarte RF, Chaudhary PM, Hu K, Yu C, Sun Q, Fuchs E, Cai B, Huang Y, Qiao J, Gottlieb D, Schultz KR, Liu M, Chen X, Chen W, Wang J, Zhang X, Li J, Huang H, Sun Z, Li F, Yang L, Zhang L, Li L, Liu K, Jin J, Liu Q, Liu D, Gao C, Fan C, Wei L, Zhang X, Hu L, Zhang W, Tian Y, Han W, Zhu J, Xiao Z, Zhou D, Zhang B, Jia Y, Zhang Y, Wu X, Shen X, Lu X, Zhan X, Sun X, Xiao Y, Wang J, Shi X, Zheng B, Chen J, Ding B, Wang Z, Zhou F, Zhang M, Zhang Y, Sun J, Xia B, Chen B, Ma L. Ai H, et al. Among authors: wang j, wang z. Heliyon. 2023 Mar 31;9(4):e14924. doi: 10.1016/j.heliyon.2023.e14924. eCollection 2023 Apr. Heliyon. 2023. PMID: 37089296 Free PMC article. Review.
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma.
Li R, Wang T, Lyv R, Wang Y, Yu Y, Yan Y, Sun Q, Xiong W, Liu W, Sui W, Huang W, Wang H, Li C, Wang J, Zou D, An G, Wang J, Qiu L, Yi S. Li R, et al. Among authors: wang h, wang j, wang y, wang t. Blood Sci. 2022 Dec 9;5(2):118-124. doi: 10.1097/BS9.0000000000000144. eCollection 2023 Apr. Blood Sci. 2022. PMID: 37228779 Free PMC article.
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemia.
Xiong W, Wang Z, Wang T, Yu Y, Huang Y, Sun H, Chen J, Lyu R, Wang H, Yan Y, Wang Q, Liu W, An G, Sui W, Huang W, Zou D, Xiao Z, Wang J, Ouyang G, Qiu L, Yi S. Xiong W, et al. Among authors: wang h, wang z, wang j, wang t, wang q. Front Immunol. 2023 May 10;14:1171539. doi: 10.3389/fimmu.2023.1171539. eCollection 2023. Front Immunol. 2023. PMID: 37234167 Free PMC article.
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
Yan Y, Lv R, Wang T, Yu Y, Huang Y, Xiong W, Li Y, Sui W, Wang Q, Huang W, An G, Zou D, Wang J, Qiu L, Yi S. Yan Y, et al. Among authors: wang j, wang t, wang q. Front Immunol. 2023 Jul 7;14:1184395. doi: 10.3389/fimmu.2023.1184395. eCollection 2023. Front Immunol. 2023. PMID: 37483630 Free PMC article.
Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial.
Xiong W, Lyu R, Yu Y, Wang T, Yan Y, Wang Y, Liu W, An G, Deng S, Xu Y, Sui W, Huang W, Zou D, Wang J, Qiu L, Yi S. Xiong W, et al. Among authors: wang j, wang y, wang t. Haematologica. 2024 May 1;109(5):1614-1618. doi: 10.3324/haematol.2023.284588. Haematologica. 2024. PMID: 38205507 Free PMC article. Clinical Trial. No abstract available.
219,318 results
You have reached the last available page of results. Please see the User Guide for more information.